Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei

Journal of Comparative Neurology

Volumn 509, Issue 4, 2008, Pages 400-421

  Suárez, Juan ^a   Bermúdez Silva, Francisco Javier ^a   Mackie, Ken ^b   Ledent, Catherine ^c   Zimmer, Andreas ^d   Cravatt, Benjamin F ^e   De Fonseca, Fernando Rodríguez ^a  

^a Hospital University Carlos Haya de Málaga   (Spain)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF BONN   (Germany)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CB1 receptor; CB2 receptor; Cerebellar cortex; Deep cerebellar nuclei; Endocannabinoid system; Immunohistochemistry; Inferior olive; Vestibular nuclei

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; PROTEIN DAGLALPHA; PROTEIN DAGLBETA; PROTEIN MAGL; PROTEIN NAPE PLD;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CEREBELLUM CORTEX; CEREBELLUM NUCLEUS; CONTROLLED STUDY; DENDRITE; GABAERGIC SYSTEM; GAIT DISORDER; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERIOR OLIVE; LEARNING; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT; SIGNAL TRANSDUCTION; VESTIBULAR NUCLEUS;

EID: 48249140762     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21774     Document Type: Article

References (81)

1. 1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation. Brain Res 1021:264-271.
2. 2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 396:113-116.
3. Benito C, Kim WK, Chavarria I, Hillard CJ, Mackie K, Tolon RM, Williams K, Romero J. 2005. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci 25:2530-2536.
4. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P. 2003. Cloning of the first sn1-dag lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468.
5. Bisogno T, Ligresti A, Di Marzo V. 2005. The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav 81:224-238.
6. Blankman JL, Simon GM, Cravatt BF. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14:1347-1356.
7. Brenowitz SD, Regehr WG. 2005. Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 45:419-31.
8. Brittis PA, Silver J, Walsh FS, Doherty P. 1996. Fibroblast growth factor receptor function is required for the orderly projection of ganglion cell axons in the developing mammalian retina. Mol Cell Neurosci 8:120-128.
9. 2 cannabinoid receptor. Eur J Pharmacol 396:141-149.
10. Chevaleyre V, Castillo PE. 2003. Heterosynaptic LTD of hippocampal gabaergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-472.
11. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA. 1995. Chemical characterization of a family of brain lipids that induce sleep. Science 268:1506-1509.
12. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Guilula NB. 1996. Molecular characterization of an enzyme that degrades neuromodulator fatty-acid amides. Nature 384:83-87.
13. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. 2001. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98:9371-9376.
14. Cristino L, De Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo D. 2006. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptor in the mouse brain. Neuroscience 139:1405-1415.
15. Dewey WL. 1986. Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
16. Diana MA, Marty A. 2004. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142:9-19.
17. Diana MA, Levenes C, Mackie K, Marty A. 2002. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J Neurosci 22:200-208.
18. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819-10824.
19. Dinh TP, Kathuria S, Piomelli D. 2004. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2 arachidonoylglycerol. Mol Pharmacol 66:1260-1264.
20. 1. J Comp Neurol 422:159-171.
21. 1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265:2081-2085.
22. Egertová M, Cravatt BF, Elphick MR. 2003. Comparative analysis of fatty acid amide hydrolase and CB(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119:481-496.
23. Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A, Serrano A, Baixeras E, Khaturia S, Navarro M, Parsons LH, Piomelli D, Rodriguez de Fonseca F. 2007. Regulation of brain anandamide by acute administration of ethanol. Biochem J 404:97-104.
24. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D. 2003. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425:90-93.
25. Gerdeman GL, Ronesi J, Lovinger DM. 2002. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
26. Giang DK, Cravatt BF. 1997. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A 94:2238-2242.
27. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D. 1999. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-363.
28. Glass M, Dragunow M, Faull RL. 1997. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299-318.
29. 2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10-23.
30. Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. 1998. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422:69-73.
31. Gulyas AI, Cravatt BF, Bracey MH, Dihn TP, Piomelli D, Boscia F, Freund TF. 2004. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20:441-458.
32. Hashimotodani Y, Ohno-Shosaku T, Kano M. 2007. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid signaling in the hippocampus. J Neurosci 27:1211-1219.
33. Herkenham M. 1995. Localization of cannabinoid receptors in brain and periphery. In: Pertwee R, editor. Cannabinoid receptors. London: Academic Press. p 145-166.
34. Herkenham M, Groen BGS, Lynn AB, deCosta BR, Richfield EK. 1991a. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res 552:301-310.
35. Herkenham M, Lynn A, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991b. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
36. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. 2005. An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108-1112.
37. 1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26:2991-3001.
38. 1 receptor is essential for cerebellum-dependent discrete motor learning. J Neurosci 26:8829-8837.
39. Kreitzer AC, Regehr WG. 2001. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:1-5RC174.
40. 1 receptor knockout mice. Science 283:401-404.
41. Leung D, Saghatelian A, Simon GM, Cravatt BF. 2006. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45:4720-4726.
42. Liu J, Wang L, Harvey-White J, Huang BX, Kim HY, Luquet S, Palmiter RD, Krystal G, Rai R, Mahadevan A, Razdan RK, Kunos G. 2007. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology [June 6 E-pub ahead of print].
43. 2 cannabinoid receptor mRNA in adult rat retina. Vis Neurosci 17:91-95.
44. Mailleux P, Vanderhaeghen JJ. 1992. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
45. Matsuda LA, Bonner TI, Lolait SJ. 1993. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550.
46. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
47. Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM, Lopez Rodriguez ML, Bajjalieh S, Stella N. 2007. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 2007 27:2883-2889.
48. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-305.
49. 2 receptors in brain. Ann N Y Acad Sci 1074:514-536.
50. Patel S, Hillard CJ. 2001. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther 297:629-637.
51. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 24th ed. London: Academic Press.
52. Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. 2004. Role of the endocannabinoid system in Alzheimer's disease: new perspectives. Life Sci 75:1907-1915.
53. Pettit DAD, Harrison MP, Olson JM, Spencer RF, Cabral GA. 1998. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Methods 51:391-402.
54. Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F. 2000. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218-224.
55. Raymond JL, Lisberger SG, Mauk MD. 1996. The cerebellum: a neuronal learning machine? Science 272:1126-1131.
56. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. 2002. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A 99:8384-8348.
57. Rodríguez de Fonseca F, Del Arco I, Martin-Calderon JL, Gorriti MA, Navarro M. 1998. Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 5:483-501.
58. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D. 2001. An anorexic lipid mediator regulated by feeding. Nature 414:209-212.
59. Rodríguez de Fonseca F, Del Arco I, Bermúdez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. 2005. The endocannabinoid system: physiology and pharmacology. Alcohol Alcoholism 40:2-14.
60. Romero J, Hillard CJ, Calero M, Rábano A. 2002. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res 100:85-93.
61. Safo PK, Regehr WG. 2005. Endocannabinoids control the induction of cerebellar LTD. Neuron 48:647-659.
62. Sheng WS, Hu S, Min X, Cabral GY, Lokensgard JR, Peterson PK. 2005. Synthetic cannabinoid WIN55212-2 inhibits generation of inflammatory mediators by IL-IB-stimulated human astrocytes. Glia 49:211-219.
63. Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A. 1996. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebral granule neurons. Proc Natl Acad Sci U S A 93:3984-3989.
64. Skosnik PD, Edwards CR, O'Donnell BF, Steffen A, Steinmetz JE, Hetrick WP. 2007. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology [July 18 E-pub ahead of print].
65. Simon GM, Cravatt BF. 2006. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281:26465-26472.
66. Stella N, Schweitzer P, Piomelli D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
67. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
68. Thomas EA, Cravatt BF, Danielson PE, Gilula NB, Sutcliffe JG. 1997. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res 50:1047-1052.
69. 1 receptors in the rat central nervous system. Neuroscience 83:393-411.
70. Valenzano KJ, Tafesse L, Lee G, Harrison JE, Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, Rabadi L, Rotshteyn Y, Chaffer SM, Turchin PI, Elsemore DA, Toth M, Koetzner L, Whiteside GT. 2005. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology 48:658-672.
71. 2 receptors. Science 310:329-332.
72. Vila A, Rosengarth A, Piomelli D, Cravatt B, Marnett LJ. 2007. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase. Biochemistry 46:9578-9585.
73. 1 cannabinoid receptors as an example. Chem Phys Lipids 121:83-89.
74. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF. 2006. A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem. 281:36569-36578.
75. Williams EJ, Walsh FS, Doherty P. 2003. The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J Cell Biol 160:481-486.
76. Wilson RI, Nicoll RA. 2001. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592.
77. Wilson RI, Nicoll RA. 2002. Endocannabinoid signaling in the brain. Science 296:678-682.
78. Wilson RI, Kunos G, Nicoll RA. 2001. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462.
79. Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Moller T, Brosnan C, Stella N. 2006. Experimental autoimmune encephalomyelitis disrupt endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci U S A 103:6362-6367.
80. 1 receptor. J Neurosci 26:4740-4751.
81. 2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17:2750-2754.